VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2025 Earnings Call Transcript

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2025 Earnings Call Transcript June 17, 2025

VistaGen Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.43, expectations were $-0.52.

Operator: Good day, everyone, and thank you for standing by. Welcome to the Vistagen Therapeutics Fiscal Year-End 2025 Corporate Update Conference Call and Webcast. Please note that today’s call is being recorded. At this time, I’d like to turn the call over to your host, Mark McPartland, Senior...